Psyence Group Receives Phase IIa Clinical Trial Approval from the UK...

From Dendrites to Drug Discovery: An Interview with Dr. Alex Kwan

PsyBio Therapeutics Latest U.S. PCT (Non-Provisional) Patent Application Accepted

Algernon Pharmaceuticals Files for Orphan Designation with the U.S. FDA for...

Small Pharma Completes Enrollment in Phase IIa DMT-Assisted Psychotherapy Clinical Trial...

Numinus Now Offers Ketamine-Assisted Therapy in Toronto

Clearmind Medicine Announces Share-Based Payment for one of the Company’s Consultants

Braxia Scientific Announces Court Approval of Class Action Settlement in Canada

PharmaTher Announces Late-Breaking Abstract Presentation of Positive Efficacy and Safety Data...

PT356 – Brom Rector – Investing in Psychedelics and The Rush...

Load more